2025-523808-75-00CompletedPhase 1
Randomised, crossover bioequivalence clinical trial of memantine 20 mg capsules versus memantine 20 mg film-coated tablets, after a single oral dose administration to healthy volunteers under fasting conditions.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 9 Oct 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- First submitted
- 18 Sept 2025
- Start date
- 24 Oct 2025
- Lead sponsor
- Laboratorios Alter S.A.
- EU CT number
- 2025-523808-75-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 24
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitario de la Princesa | Madrid | Spain | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.